Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    23924660 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Boceprevir/Peginterferon/Ribavirin for Chronic Hepatitis C: Erythropoietin Use Versus Ribavirin Dose Reduction for Anemia (P06086 AM2)
Condition: Hepatitis C, Chronic
Interventions: Drug: Boceprevir;   Drug: Peginterferon alfa-2b (PEG2b);   Drug: Ribavirin (RBV);   Drug: Erythropoietin

Study has passed its completion date and status has not been verified in more than two years.